112 related articles for article (PubMed ID: 19948165)
1. Protection of oligodendrocyte precursor cells by low doses of HSP90 inhibitors in cell culture.
Cid C; Alcazar A
Exp Neurol; 2010 Sep; 225(1):29-33. PubMed ID: 19948165
[TBL] [Abstract][Full Text] [Related]
2. High cytotoxic sensitivity of the oligodendrocyte precursor cells to HSP90 inhibitors in cell cultures.
Alcazar A; Cid C
Exp Neurol; 2009 Apr; 216(2):511-4. PubMed ID: 19162015
[TBL] [Abstract][Full Text] [Related]
3. Anti-heat shock protein 90beta antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis.
Cid C; Alvarez-Cermeño JC; Salinas M; Alcázar A
J Neurochem; 2005 Oct; 95(2):349-60. PubMed ID: 16135098
[TBL] [Abstract][Full Text] [Related]
4. Antibodies reactive to heat shock protein 90 induce oligodendrocyte precursor cell death in culture. Implications for demyelination in multiple sclerosis.
Cid C; Alvarez-Cermeño JC; Camafeita E; Salinas M; Alcázar A
FASEB J; 2004 Feb; 18(2):409-11. PubMed ID: 14688203
[TBL] [Abstract][Full Text] [Related]
5. Effects of interferon-beta on oligodendroglial cells.
Heine S; Ebnet J; Maysami S; Stangel M
J Neuroimmunol; 2006 Aug; 177(1-2):173-80. PubMed ID: 16753226
[TBL] [Abstract][Full Text] [Related]
6. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
[TBL] [Abstract][Full Text] [Related]
7. Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis.
Batulan Z; Taylor DM; Aarons RJ; Minotti S; Doroudchi MM; Nalbantoglu J; Durham HD
Neurobiol Dis; 2006 Nov; 24(2):213-25. PubMed ID: 16950627
[TBL] [Abstract][Full Text] [Related]
8. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Dello Russo C; Polak PE; Mercado PR; Spagnolo A; Sharp A; Murphy P; Kamal A; Burrows FJ; Fritz LC; Feinstein DL
J Neurochem; 2006 Dec; 99(5):1351-62. PubMed ID: 17064348
[TBL] [Abstract][Full Text] [Related]
9. Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
Xiao L; Guo D; Hu C; Shen W; Shan L; Li C; Liu X; Yang W; Zhang W; He C
Glia; 2012 Jul; 60(7):1037-52. PubMed ID: 22461009
[TBL] [Abstract][Full Text] [Related]
10. Dopamine-induced toxicity is synergistically potentiated by simultaneous HSP-90 and Akt inhibition in oligodendrocyte progenitors.
Hemdan S; Almazan G
J Neurochem; 2008 May; 105(4):1223-34. PubMed ID: 18194434
[TBL] [Abstract][Full Text] [Related]
11. HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
van der Kraan AG; Chai RC; Singh PP; Lang BJ; Xu J; Gillespie MT; Price JT; Quinn JM
Biochem J; 2013 Apr; 451(2):235-44. PubMed ID: 23379601
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin regulates oligodendroglial process dynamics and survival.
Miron VE; Rajasekharan S; Jarjour AA; Zamvil SS; Kennedy TE; Antel JP
Glia; 2007 Jan; 55(2):130-43. PubMed ID: 17078030
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase activity mediates acquired resistance towards structurally diverse HSP90 inhibitors.
Chai RC; Vieusseux JL; Lang BJ; Nguyen CH; Kouspou MM; Britt KL; Price JT
Mol Oncol; 2017 May; 11(5):567-583. PubMed ID: 28306192
[TBL] [Abstract][Full Text] [Related]
14. Haplotype matching is not an essential requirement to achieve remyelination of demyelinating CNS lesions.
Tepavcević V; Blakemore WF
Glia; 2006 Dec; 54(8):880-90. PubMed ID: 17006890
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo.
Butt AM; Dinsdale J
Exp Neurol; 2005 Mar; 192(1):125-33. PubMed ID: 15698626
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.
Ohba S; Hirose Y; Yoshida K; Yazaki T; Kawase T
J Neurosurg; 2010 Jan; 112(1):33-42. PubMed ID: 19408974
[TBL] [Abstract][Full Text] [Related]
17. Alterations in hippocampal myelin and oligodendrocyte precursor cells during epileptogenesis.
Luo Y; Hu Q; Zhang Q; Hong S; Tang X; Cheng L; Jiang L
Brain Res; 2015 Nov; 1627():154-64. PubMed ID: 26433043
[TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
[TBL] [Abstract][Full Text] [Related]
19. Protection of murine neural progenitor cells by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin in the low nanomolar concentration range.
Wang G; Krishnamurthy K; Tangpisuthipongsa D
J Neurochem; 2011 May; 117(4):703-11. PubMed ID: 21395580
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
